Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2221


Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease.

Hodgson R, Reason T, Trueman D, Wickstead R, Kusel J, Jasilek A, Claxton L, Taylor M, Pulikottil-Jacob R.

Adv Ther. 2017 Oct 10. doi: 10.1007/s12325-017-0620-x. [Epub ahead of print]


Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration.

Hanhart J, Comaneshter DS, Freier Dror Y, Vinker S.

BMC Ophthalmol. 2017 Oct 10;17(1):189. doi: 10.1186/s12886-017-0586-0.


Consecutive case series of 244 age-related macular degeneration patients undergoing implantation with an extended macular vision IOL.

Qureshi MA, Robbie SJ, Hengerer FH, Auffarth GU, Conrad-Hengerer I, Artal P.

Eur J Ophthalmol. 2017 Oct 5:0. doi: 10.5301/ejo.5001052. [Epub ahead of print]


Automated detection of foveal center in SD-OCT images using the saliency of retinal thickness maps.

Niu S, Chen Q, de Sisternes L, Leng T, Rubin DL.

Med Phys. 2017 Oct 4. doi: 10.1002/mp.12614. [Epub ahead of print]


Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration.

Khneizer G, Al-Taee A, Bastani B.

J Nephropathol. 2017 Jul;6(3):134-137. doi: 10.15171/jnp.2017.23. Epub 2017 Feb 5.


Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration.

Garweg JG, Niderprim SA, Russ HM, Pfister IB.

J Ocul Pharmacol Ther. 2017 Sep 27. doi: 10.1089/jop.2017.0006. [Epub ahead of print]


Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells.

Subramani M, Ponnalagu M, Krishna L, Jeyabalan N, Chevour P, Sharma A, Jayadev C, Shetty R, Begum N, Archunan G, Das D.

Sci Rep. 2017 Sep 25;7(1):12242. doi: 10.1038/s41598-017-12496-z.


Proteolytic Degradation and Inflammation Play Critical Roles in Polypoidal Choroidal Vasculopathy.

Kumar S, Nakashizuka H, Jones A, Lambert A, Zhao X, Shen M, Parker M, Wang S, Berriochoa Z, Fnu A, VanBeuge S, Chévez-Barrios P, Tso M, Rainier J, Fu Y.

Am J Pathol. 2017 Sep 20. pii: S0002-9440(17)30443-1. doi: 10.1016/j.ajpath.2017.08.025. [Epub ahead of print]


Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes with Vascular Endothelial Growth Factor Inhibition.

Lee WJ, Kim YK, Kim YW, Jeoung JW, Kim SH, Heo JW, Yu HG, Park KH.

J Glaucoma. 2017 Sep 19. doi: 10.1097/IJG.0000000000000776. [Epub ahead of print]


Complement factor H in AMD: Bridging genetic associations and pathobiology.

Toomey CB, Johnson LV, Bowes Rickman C.

Prog Retin Eye Res. 2017 Sep 18. pii: S1350-9462(17)30038-1. doi: 10.1016/j.preteyeres.2017.09.001. [Epub ahead of print] Review.


Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration.

Fu H, Zhang B, Tong J, Bedell H, Zhang H, Yang Y, Nie C, Luo Y, Liu X.

PLoS One. 2017 Sep 18;12(9):e0185070. doi: 10.1371/journal.pone.0185070. eCollection 2017.


Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal Neovascularization.

Park TK, Lee SH, Choi JS, Nah SK, Kim HJ, Park HY, Lee H, Lee SHS, Park K.

Mol Ther Nucleic Acids. 2017 Sep 15;8:26-35. doi: 10.1016/j.omtn.2017.05.012. Epub 2017 Jun 1.


Recombinant humanized anti-vascular endothelial growth factor monoclonal antibody efficiently suppresses laser-induced choroidal neovascularization in rhesus monkeys.

Ji WW, Yu DA, Yang P, Fang P, Cao YX, Li H, Xie N, Yan SS.

Eur J Pharm Sci. 2017 Sep 13;109:624-630. doi: 10.1016/j.ejps.2017.09.021. [Epub ahead of print]


An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light Exposure.

Hallam D, Collin J, Bojic S, Chichagova V, Buskin A, Xu Y, Lafage L, Otten EG, Anyfantis G, Mellough C, Przyborski S, Alharthi S, Korolchuk V, Lotery A, Saretzki G, McKibbin M, Armstrong L, Steel D, Kavanagh D, Lako M.

Stem Cells. 2017 Sep 15. doi: 10.1002/stem.2708. [Epub ahead of print]


Cataract Surgery in Patients With Wet Macular Degeneration.

Ober MD, Fine HF, Saraf SS.

Ophthalmic Surg Lasers Imaging Retina. 2017 Sep 1;48(9):700-704. doi: 10.3928/23258160-20170829-03. No abstract available.


A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patients with Wet Age-Related Macular Degeneration from Portugal.

Silva R, Goncalves C, Meireles A, Teixeira C, Rosa P, Monteiro-Grillo M, Canelas J, Carneiro A, Flores R.

Acta Med Port. 2017 Jun 30;30(6):449-456. doi: 10.20344/amp.8217. Epub 2017 Jun 30.


Associations Between Vitamin D Intake and Progression to Incident Advanced Age-Related Macular Degeneration.

Merle BMJ, Silver RE, Rosner B, Seddon JM.

Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4569-4578. doi: 10.1167/iovs.17-21673.


Plasma metabolomic study in Chinese patients with wet age-related macular degeneration.

Luo D, Deng T, Yuan W, Deng H, Jin M.

BMC Ophthalmol. 2017 Sep 6;17(1):165. doi: 10.1186/s12886-017-0555-7.


Recent developments in age-related macular degeneration: a review.

Al-Zamil WM, Yassin SA.

Clin Interv Aging. 2017 Aug 22;12:1313-1330. doi: 10.2147/CIA.S143508. eCollection 2017. Review.


TGF-β participates choroid neovascularization through Smad2/3-VEGF/TNF-α signaling in mice with Laser-induced wet age-related macular degeneration.

Wang X, Ma W, Han S, Meng Z, Zhao L, Yin Y, Wang Y, Li J.

Sci Rep. 2017 Aug 29;7(1):9672. doi: 10.1038/s41598-017-10124-4.

Supplemental Content

Loading ...
Support Center